Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities

被引:22
|
作者
Dickson, Stephen D. [1 ]
Thomas, Isac C. [1 ]
Bhatia, Harpreet S. [1 ]
Nishimura, Marin [1 ]
Mahmud, Ehtisham [1 ]
Tu, Xin M. [1 ]
Lin, Tuo [1 ]
Adler, Eric [1 ]
Greenberg, Barry [1 ]
Alshawabkeh, Laith [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA
来源
关键词
alcohol; cardiac hospitalization; cardiotoxicity; cocaine; heart failure; CLINICAL CHARACTERISTICS; OUTCOMES; MORTALITY; CARDIOMYOPATHY; FEATURES; TRENDS;
D O I
10.1161/JAHA.120.018370
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although methamphetamine abuse is associated with the development of heart failure (HF), nationwide data on methamphetamine-associated HF (MethHF) hospitalizations are limited. This study evaluates nationwide HF hospitalizations associated with substance abuse to better understand MethHF prevalence trends and the clinical characteristics of those patients. Methods and Results This cross-sectional period-prevalence study used hospital discharge data from the National Inpatient Sample to identify adult primary HF hospitalizations with a secondary diagnosis of abuse of methamphetamines, cocaine, or alcohol in the United States from 2002 to 2014. All 2014 MethHF admissions were separated by regional census division to evaluate geographical distribution. Demographics, payer information, and clinical characteristics of MethHF hospitalizations were compared with all other HF hospitalizations. Total nationwide MethHF hospitalizations increased from 547 in 2002 to 6625 in 2014 with a predominance on the West Coast. Methamphetamine abuse was slightly more common among primary HF hospitalizations compared with all-cause hospitalizations (7.4 versus 6.4 per 1000; Cohen h=0.012; P<0.001). Among HF hospitalizations, patients with MethHF were younger (mean age, 48.9 versus 72.4 years; Cohen d=1.93; P<0.001), more likely to be on Medicaid (59.4% versus 8.8%; Cohen h=1.16; P<0.001) or uninsured (12.0% versus 2.6%; Cohen h=0.36; P<0.001), and more likely to present to urban hospitals (43.8% versus 28.3%; Cohen h=0.32; P<0.001) than patients with non-methamphetamine associated HF. Patients with MethHF had higher rates of psychiatric comorbidities and were more likely to leave the hospital against medical advice. Conclusions MethHF hospitalizations have significantly increased in the United States, particularly on the West Coast. Coordinated public health policies and systems of care are needed to address this rising epidemic.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Variation in Methamphetamine-Associated Heart Failure Hospitalizations Across the United States
    Manja, Veena
    Sandhu, Alexander Tarlochan Singh
    Frayne, Susan
    Asch, Steven
    Mcgovern, Mark
    Chen, Cheng
    Heidenreich, Paul
    [J]. JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 91 - 94
  • [2] INCREASING METHAMPHETAMINE-ASSOCIATED HEART FAILURE HOSPITALIZATIONS IN THE UNITED STATES
    Dickson, Stephen D.
    Thomas, Isac
    Nishimura, Marin
    Ma, Janet
    Arend, William
    Adler, Eric
    Greenberg, Barry
    Alshawabkeh, Laith
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 710 - 710
  • [3] Disparities in Prevalence and Trend of Methamphetamine-Associated Cardiomyopathy in the United States
    Bhuiyan, Md. Shenuarin
    Faisal, Abu Saleh Mosa
    Venkataraj, Maamannan
    Goeders, Nicholas E.
    Bailey, Steven R.
    Conrad, Steven A.
    Vanchiere, John A.
    Orr, A. Wayne
    Kevil, Christopher G.
    Bhuiyan, Mohammad Alfrad Nobel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) : 1881 - 1883
  • [4] METHAMPHETAMINE ASSOCIATED HEART FAILURE HOSPITALIZATIONS AMONG VETERANS IN THE UNITED STATES
    Manja, Veena
    Sandhu, Alex
    Chen, Cheng
    Asch, Steven
    Frayne, Susan
    Heidenreich, Paul A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 492 - 492
  • [5] Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018
    Zhao, Susan X.
    Deluna, Andres
    Kelsey, Kate
    Wang, Clifford
    Swaminathan, Aravind
    Staniec, Allison
    Crawford, Michael H.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (07): : E007638
  • [6] Heart Failure-Associated Hospitalizations in the United States
    Blecker, Saul
    Paul, Margaret
    Taksler, Glen
    Ogedegbe, Gbenga
    Katz, Stuart
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1259 - 1267
  • [7] Cardiopulmonary Exercise Function in Methamphetamine-Associated Heart Failure
    Xiao, Sophia Y.
    Cedarbaum, Emily R.
    Li, Danny
    Wu, Yuaner
    Wang, Teresa
    Durstenfeld, Matthew S.
    Hsue, Priscilla
    [J]. CIRCULATION, 2023, 148
  • [8] PREDICTORS OF ISCHEMIC EVALUATIONS IN METHAMPHETAMINE-ASSOCIATED HEART FAILURE
    Kersey, Cooper B.
    Hidano, Danee
    Chiang, Joey
    Doshi, Shradha
    Longenecker, Christopher
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 415 - 415
  • [9] Methamphetamine-associated heart failure: a systematic review of observational studies
    Manja, Veena
    Nrusimha, Ananya
    Gao, Ya
    Sheikh, Aleesha
    McGovern, Mark
    Heidenreich, Paul A.
    Sandhu, Alex Tarlochan Singh
    Asch, Steven
    [J]. HEART, 2023, 109 (03) : 168 - 177
  • [10] Methamphetamine-associated cardiomyopathy: A previously unrecognized cause of heart failure
    Robinson, MR
    Turnipseed, SD
    Glatter, KA
    [J]. CIRCULATION, 2004, 110 (17) : 366 - 366